Skip to content

ASH

Ashland Inc.

NYSE · Basic Materials · Chemicals - Specialty · US

$72.93
−0.37%
Ask drillr
  • Aug 24, 2026, 11:00 UTC

    Ashland Inc. launched permexa sodium caprate, an intestinal permeation enhancer for oral biologic drug development, announced on August 24, 2026, in Wilmington, Delaware.

  • Aug 18, 2026, 07:50 UTC

    Bank of America Corp DE reduced its stake in Ashland Inc. by 4.9% by selling 22,944 shares during the quarter, according to its Form 13F filing.

  • Aug 7, 2026, 21:00 UTC

    Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share on the company's common stock on August 7, 2026.

  • Aug 7, 2026, 20:14 UTC

    Ashland is exploring a sale after receiving takeover interest, according to a report.

  • Aug 7, 2026, 12:08 UTC

    Lakshmi Tulasi Inturi has been appointed head of human resources at Wendt India, effective as of the announcement date.

  • Jul 31, 2026, 00:00 UTC

    Ashland Inc. amended its accounts receivable securitization facility, extending the termination date to July 28, 2028 and maintaining maximum commitments of $70 million, with PNC Bank as administrative agent.

  • Jul 29, 2026, 19:04 UTC

    Ashland reported higher sales across all four business units in its fiscal third quarter of 2026.

  • Jul 29, 2026, 00:30 UTC

    Ashland reported Q3 2026 earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share and down from $1.04 per share a year ago.

  • Jul 28, 2026, 19:03 UTC

    Ashland is nearing a settlement with activist investor Ancora, which includes adding two board members and establishing a capital allocation committee.

  • Jun 18, 2026, 14:34 UTC

    Activist investor Cruiser Capital is pushing for the sale of Ashland.

  • Jun 9, 2026, 17:38 UTC

    Activist investor Ancora has taken a stake in Ashland.